Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies.
作者信息
Avezum A, Pais P, Flather M D, Anand S, Yusuf S
机构信息
Division of Cardiology, McMaster University, Hamilton General Hospital, Ontario, Canada.
出版信息
Indian Heart J. 1995 Mar-Apr;47(2):95-105.
PMID:7590849
Abstract
摘要
相似文献
1
Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies.
Indian Heart J. 1995 Mar-Apr;47(2):95-105.
2
Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials.
N Engl J Med. 1996 Nov 28;335(22):1660-7. doi: 10.1056/NEJM199611283352207.
3
Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.血管紧张素II受体阻滞剂与心肌梗死：随机临床试验的最新分析
J Hypertens. 2009 May;27(5):941-6. doi: 10.1097/HJH.0b013e32832961ed.
4
AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.血管紧张素Ⅱ1型受体阻断用于预防心肌梗死后心血管事件
Expert Rev Cardiovasc Ther. 2004 Nov;2(6):891-902. doi: 10.1586/14779072.2.6.891.
5
Adjunctive therapy for myocardial infarction.心肌梗死的辅助治疗
Arq Bras Cardiol. 1995 Jul;65(1):97-110.
6
[Multi-drug management after myocardial infarct].
Wien Klin Wochenschr. 1997;109 Suppl 2:17-24.
7
Management of postmyocardial infarction in the elderly patient.
Clin Geriatr Med. 1996 Feb;12(1):169-80.
8
Potential novel pharmacological therapies for myocardial remodelling.针对心肌重塑的潜在新型药物疗法。
Cardiovasc Res. 2009 Feb 15;81(3):519-27. doi: 10.1093/cvr/cvn317. Epub 2008 Nov 19.
9
[Adjuvant therapy in myocardial infarction].
Med Monatsschr Pharm. 1998 Jan;21(1):16-8.
10
Safety and efficacy of first-line antihypertensives.一线抗高血压药物的安全性与有效性。
J Fam Pract. 1997 Jun;44(6):530-1.
Zotero 插件